Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters
Valentin Sencio, Arnaud Machelart, Cyril Robil, et al.
Gut Microbes (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 188
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia
Lucie Bernard, Mericien Venzon, Jon Klein, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 137
A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
Raphaela Iris Lau, Qi Su, I.S. Lau, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. 256-265
Open Access | Times Cited: 50
The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
Farzaneh Fakharian, Siva Thirugnanam, David A. Welsh, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1849-1849
Open Access | Times Cited: 43
Gut feelings on short-chain fatty acids to regulate respiratory health
Samantha N. Rowland, Christopher G. Green, John R. Halliwill, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 2
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 47
Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters
Lou Delval, Aline Hantute-Ghesquier, Valentin Sencio, et al.
Nature Aging (2023) Vol. 3, Iss. 7, pp. 829-845
Open Access | Times Cited: 27
Faecalibacterium duncaniae as a novel next generation probiotic against influenza
Loïc Chollet, Séverine Heumel, Lucie Deruyter, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Role of Microbiota in Viral Infections and Pathological Progression
Taketoshi Mizutani, Aya Ishizaka, Michiko Koga, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 950-950
Open Access | Times Cited: 35
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways
Laure‐Alix Clerbaux, Julija Filipovska, Amalia Muñoz, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5400-5400
Open Access | Times Cited: 30
Butyrate: Connecting the gut-lung axis to the management of pulmonary disorders
Renan Oliveira Corrêa, Pollyana Ribeiro Castro, René Moser, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 29
Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms (2023) Vol. 11, Iss. 2, pp. 452-452
Open Access | Times Cited: 22
Gut microbiota in COVID-19: new insights from inside
Bingqian Zhou, Xiaoqi Pang, Jingyi Wu, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions
Yong Qiu, Chunheng Mo, Lu Chen, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 7
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Laure‐Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4464-4464
Open Access | Times Cited: 23
The gut-lung axis in influenza A: the role of gut microbiota in immune balance
Guosen Ou, Huachong Xu, Jialin Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
A narrative review of alternative transmission routes of COVID 19: what we know so far
Alyexandra Arienzo, Valentina Gallo, Federica Tomassetti, et al.
Pathogens and Global Health (2023) Vol. 117, Iss. 8, pp. 681-695
Open Access | Times Cited: 13
What Makes the Gut-Lung Axis Working? From the Perspective of Microbiota and Traditional Chinese Medicine
Hui Wang, Ying Wang
Canadian Journal of Infectious Diseases and Medical Microbiology (2024) Vol. 2024, pp. 1-15
Open Access | Times Cited: 5
The gut microbe pair of Oribacterium sp. GMB0313 and Ruminococcus sp. GMB0270 confers complete protection against SARS-CoV-2 infection by activating CD8+ T cell-mediated immunity
Mingda Wang, Enkhchimeg Lkhagva, Sura Kim, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature
Kimia Vakili, Mobina Fathi, Shirin Yaghoobpoor, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters
Valentin Sencio, Nicolas Benech, Cyril Robil, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19
Laure‐Alix Clerbaux, Sally A. Mayasich, Amalia Muñoz, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5691-5691
Open Access | Times Cited: 19
Exploring gut–lung axis crosstalk in SARS‐CoV‐2 infection: Insights from a hACE2 mouse model
Yu Zhang, Ma Yifang, Weiyang Sun, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 4
The gut microbiota contributes to the infection of bovine viral diarrhea virus in mice
Zecai Zhang, Jiang Huang, Chuang Li, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 4
Gastrointestinal microbiota and metabolites possibly contribute to distinct pathogenicity of SARS-CoV-2 proto or its variants in rhesus monkeys
Hongyu Chen, Junbin Wang, Kaiyun Ding, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top